Immunovia AB (publ)
Market Cap
$55.28M
P/E Ratio
-0.02
EPS
$-7.80
Dividend Yield
0.00%
52-Week Range
$0.16 — $7.83
Volume
338.68K
Avg Volume
21.02K
Beta
2.77
P/E (TTM)
-0.02
Forward P/E
—
PEG Ratio
0.06
P/S (TTM)
87.63
P/B (TTM)
1.43
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-5.64%
ROA (TTM)
-1.65%
ROIC
—
Gross Margin
-23.38%
Operating Margin
-117.39%
Net Margin
—
Debt/Equity
0.01
Current Ratio
3.42
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.21%
EPS Growth (5Y)
+0.09%
Sales Growth (3Y)
+0.11%
Sales Growth (5Y)
+0.33%
EPS Est (This Year)
$-0.14
EPS Est (Next Year)
$-0.07
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.15
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
305.39M
Float
296.33M
Free Float %
97.03%
RSI (14)
30.67
SMA 20
$0.23
SMA 50
$0.37
SMA 200
$0.39
ATR (14)
0.01
Volatility (Week)
0.03%
Volatility (Month)
0.07%
Pattern
—
1 Day
-4.31%
1 Week
-7.11%
1 Month
-22.78%
3 Months
—
6 Months
—
1 Year
—
YTD
-11.89%
All-Time High
$0.93
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
SE
Exchange
LSE
IPO Date
2018-01-26
Employees
9
CEO
Jeff Borcherding
Index Membership
—
Website
https://www.immunovia.com
Immunovia AB (publ) (0G8X.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $55.28M, a P/E ratio of -0.02, 0G8X.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0G8X.L against other stocks using dozens of fundamental and technical filters.
Immunovia AB (publ) (0G8X.L) has a trailing twelve-month (TTM) P/E ratio of -0.02. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Immunovia AB (publ) (0G8X.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Immunovia AB (publ) (0G8X.L) has a market capitalization of $55.28 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Immunovia AB (publ) (0G8X.L) has returned -11.89% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.